Cryopreservation of ovarian tissue in breast cancer patients: 10 years of experience

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol.36(3),237–248 (2012).▪ Shows the latest international descriptive epidemiological data on invasive breast cancer patients.
  MedlineGoogle Scholar
• 2  Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum. Reprod. Update7(6),535–543 (2001).
  Medline CASGoogle Scholar
• 3  Larsen EC, Müller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J. Clin. Endocrinol. Metab.88(11),5307–5314 (2003).
  Medline CASGoogle Scholar
• 4  Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J. Clin. Oncol.24(36),5769–5779 (2006).
  Medline CASGoogle Scholar
• 5  Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer. Crit. Rev. Oncol. Hematol.74(3),175–192 (2010).
  MedlineGoogle Scholar
• 6  Hulvat MC, Jeruss JS. Maintaining fertility in young women with breast cancer. Curr. Treat. Options Oncol.10(5–6),308–317 (2009).
  MedlineGoogle Scholar
• 7  Donnez J, Jadoul P, Squifflet J et al. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract. Res. Clin. Obstet. Gynaecol.24(1),87–100 (2010).
  MedlineGoogle Scholar
• 8  Omland AK, Fedorcsák P, Storeng R, Dale PO, Abyholm T, Tanbo T. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility. Hum. Reprod.16(12),2587–2592 (2001).
  Medline CASGoogle Scholar
• 9  Fabbri R, Pasquinelli G, Keane D, Magnani V, Paradisi R, Venturoli S. Optimization of protocols for human ovarian tissue cryopreservation with sucrose, 1,2-propanediol and human serum. Reprod. Bio. Med. Online21(6),819–828 (2010).▪▪ Presents the optimization of the cryopreservation protocols, testing different concentrations of cryoprotectants and human serum.
  Medline CASGoogle Scholar
• 10  Fabbri R, Vicenti R, Macciocca M et al. Cryopreservation of ovarian tissue in pediatric patients. Obstet. Gynecol. Int.2012,910698 (2012).
  Medline CASGoogle Scholar
• 11  Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr. Rev.17(2),121–155 (1996).
  Medline CASGoogle Scholar
• 12  WHO. Tumours of the Breast and Female Genital Organs (3rd Edition). IARC Press, Lyon, France (2003).
  Google Scholar
• 13  Lee SJ, Schover LR, Partridge AH et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol.24(18),2917–2931 (2006).
  MedlineGoogle Scholar
• 14  Del Mastro L, Boni L, Michelotti A et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA306(3),269–276 (2011).
  Medline CASGoogle Scholar
• 15  Gerber B, von Minckwitz G, Stehle H et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J. Clin. Oncol.29(17),2334–2341 (2011).
  Medline CASGoogle Scholar
• 16  Kim SS, Lee JR, Jee BC et al. Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clin. Obstet. Gynaecol.53(4),740–752 (2010).
  CASGoogle Scholar
• 17  Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J. Clin. Oncol.23(19),4347–4353 (2005).
  Medline CASGoogle Scholar
• 18  Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J. Clin. Oncol.26(16),2630–2635 (2008).
  Medline CASGoogle Scholar
• 19  Ben-Haroush A, Farhi J, Ben-Aharon I, Sapir O, Pinkas H, Fisch B. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols. Isr. Med. Assoc. J.13(12),753–756 (2011).
  MedlineGoogle Scholar
• 20  Checa Vizcaíno MA, Corchado AR, Sastre I et al. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. Reprod. Biomed. Online24(6),606–610 (2012).
  Medline CASGoogle Scholar
• 21  Huang JY, Chian RC, Gilbert L et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients. Am. J. Surg.200(1),177–183 (2010).
  MedlineGoogle Scholar
• 22  Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod. Biomed. Online20(5),634–638 (2010).
  Medline CASGoogle Scholar
• 23  Sánchez-Serrano M, Novella-Maestre E, Roselló-Sastre E, Camarasa N, Teruel J, Pellicer A. Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum. Reprod.24(9),2238–2243 (2009).▪ The authors perform a detailed immunohistochemical analysis to check the presence of micrometastases in the ovarian tissue of breast cancer patients, suggesting the safety of the cryopreservation procedure.
  MedlineGoogle Scholar
• 24  Rosendahl M, Timmermans Wielenga V, Nedergaard L et al. Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil. Steril.95(6),2158–2161 (2011).
  MedlineGoogle Scholar
• 25  Azem F, Hasson J, Ben-Yosef D et al. Histologic evaluation of fresh human ovarian tissue before cryopreservation. Int. J. Gynecol. Pathol.29(1),19–23 (2010).
  MedlineGoogle Scholar
• 26  Schmidt KL, Byskov AG, Andersen AN, Müller J, Andersen CY. Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum. Reprod.18(6),1158–1164 (2003).▪ Reports a heterogeneous distribution of primordial follicles in the ovarian cortex and a significant negative linear correlation between follicular density and age.
  Medline CASGoogle Scholar
• 27  Qu J, Godin PA, Nisolle M, Donnez J. Distribution and epidermal growth factor receptor expression of primordial follicles in human ovarian tissue before and after cryopreservation. Hum. Reprod.15(2),302–310 (2000).
  Medline CASGoogle Scholar
• 28  Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugières L, Jouannet P. Human ovarian tissue cryopreservation: indications and feasibility. Hum. Reprod.17(6),1447–1452 (2002).
  MedlineGoogle Scholar
• 29  Campos JR, Rosa-e-Silva JC, Carvalho BR, Vireque AA, Silva-de-Sá MF, Rosa-e-Silva AC. Cryopreservation time does not decrease follicular viability in ovarian tissue frozen for fertility preservation. Clinics66(12),2093–2097 (2011).
  MedlineGoogle Scholar
• 30  Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum. Reprod.23(3),699–708 (2008).
  MedlineGoogle Scholar
• 31  Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum. Reprod. Update8(2),141–154 (2002).
  MedlineGoogle Scholar
• 32  Von Wolff M, Donnez J, Hovatta O et al. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy – a technique in its infancy but already successful in fertility preservation. Eur. J. Cancer45(9),1547–1553 (2009).
  MedlineGoogle Scholar
• 33  Janse F, Donnez J, Anckaert E, de Jong FH, Fauser BC, Dolmans MM. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment. J. Clin. Endocrinol. Metab.96(4),1136–1144 (2011).
  Medline CASGoogle Scholar
• 34  Greve T, Schmidt KT, Kristensen SG, Ernst E, Andersen CY. Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue. Fertil. Steril.97(6),1394–1398e1 (2012).
  MedlineGoogle Scholar
• 35  Kim SS. Assessment of long term endocrine function after transplantation of frozen-thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study. J. Assist. Reprod. Genet.29(6),489–493 (2012).
  MedlineGoogle Scholar
• 36  Stern CJ, Toledo MG, Hale LG, Gook DA, Edgar DH. The first Australian experience of heterotopic grafting of cryopreserved ovarian tissue: evidence of establishment of normal ovarian function. Aust. N. Z. J. Obstet. Gynaecol.51(3),268–275 (2011).
  MedlineGoogle Scholar
• 37  Revel A, Laufer N, Ben Meir A, Lebovich M, Mitrani E. Micro-organ ovarian transplantation enables pregnancy: a case report. Hum. Reprod.26(5),1097–1103 (2011).
  MedlineGoogle Scholar
• 38  Piver P, Amiot C, Agnani G et al. Two pregnancies obtained after a new technique of autotransplantation of cryopreserved ovarian tissue. Presented at: 25th Annual Meeting of ESHRE. 28 June–1 July 2009, Amsterdam, The Netherlands (2009).
  Google Scholar
• 39  Silber SJ. Ovary cryopreservation and transplantation for fertility preservation. Mol. Hum. Reprod.18(2),59–67 (2011).
  MedlineGoogle Scholar
• 40  Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet379(9815),588 (2012).
  MedlineGoogle Scholar
• 41  García Rada A. Spanish woman becomes pregnant through ovarian tissue transplantation. BMJ5,344 (2012).
  Google Scholar
• 42  Grynberg M, Poulain M, Sebag-Peyrelevade S, le Parco S, Fanchin R, Frydman N. Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil. Steril.97(6),1260–1268 (2012).▪ Describes the first 18 live births after orthotopic transplantation of frozen–thawed ovarian tissue in patients with malignant diseases or treated with high doses of chemotherapy for benign diseases.
  MedlineGoogle Scholar
• 43  Donnez J, Jadoul P, Pirard C et al. Live birth after transplantation of frozen-thawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil. Steril.98(3),720–725. (2012).
  MedlineGoogle Scholar
• 44  Sánchez-Serrano M, Crespo J, Mirabet V. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil. Steril.93(1),268.e11–e13 (2010).▪▪ Describes the first live births of healthy babies after orthotopic transplantation of cryopreserved ovarian tissue in a breast cancer patient.
  Google Scholar
• 101  Incidence, mortality, and survival of breast cancer at national and regional levels by the National Institute for the Study and Treatment of Cancer. www.tumori.net/it3/datitalia.php?page=sintesi&s1=sint&s2=ita&s3=sint (Accessed 28 June 2012)
  Google Scholar